John Harry Cross III insider trades

Open-market stock purchases and sales by John Harry Cross III, Chief Financial Officer at Senti Biosciences, Inc, from SEC Form 4 filings since Jul 2, 2020.

Recent trades

No open-market trades in the last 12 months.

Companies traded

SNTI Senti Biosciences, Inc: other filings, last Mar 7, 2025
SONN Sonnet BioTherapeutics Holdings, Inc: other filings, last Dec 11, 2023

Get free alerts when John Harry Cross III files a new trade →